Introduction
The role of angiotensin II (All)' in salt and water homeostasis has been increasingly well described in recent years. In addition to its role in aldosterone synthesis, All alters the slope ofosmolar antidiuretic hormone release (1) , produces a central dipsogenic response and salt appetite (1) , and enhances salt and water transport by the small intestine (2, 3) and colon (2, 4, 5) .
Since the demonstration by Hughes-Jones et al. in 1949 (6) that systemic infusions of a crude renin preparation produced natriuresis, numerous investigators have examined the role of the renin-angiotensin system, and particularly All, in renal salt and water transport. Clearance studies in several species demonstrated that, in general, systemic infusion of All at rates <100 ng kg-'-min-' produced antinatriuresis, whereas higher infusion rates produced natriuresis (7) . When measured, the filtration fraction rose at all All infusion rates. Since an increased filtration fraction favors proximal tubular volume reabsorption via peritubular mechanisms, a direct effect of All on proximal function could not be ascertained by these studies. Though several micropuncture studies utilizing systemic All administration found no effect on proximal volume reabsorption (8) (9) (10) , other studies applying All directly to the peritubular surface found a biphasic dose response. Steven (1 1) found inhibition of proximal volume reabsorption when 2 X 10-8 M All was infused into superficial peritubular capillaries. Spinelli and Walther (12) applied All to the decapsulated cortical surface and found stimulation of proximal reabsorption at -10-10 M, but inhibition at -I0-' M. Harris and Young (13) , using in vivo microperfusion of both lumen and capillaries, showed maximal stimulation of sodium efflux from the lumen at peritubular concentrations of 10" M, but inhibition at 10-6 M.
While suggesting a direct effect of All, these studies leave several questions unanswered. First, only superficial convolutions were examined. Since deep nephrons differ from superficial ones in a number of ways, including lower single-nephron renin activities (14) and higher volume reabsorptive rates (15) , the response of deep nephrons to All is of interest. Second, renal nerves were presumably intact in the studies cited. Since All is known to enhance norepinephrine release from sympathetic nerve endings, and since catecholamines per se can influence proximal reabsorption (16) , a direct effect of AII on the epithelium cannot be concluded. Third, All may be vasoconstrictive, particularly at high doses, and thus resistance changes in peritubular capillaries induced during All infusion have been suggested (17) .
The isolated, perfused tubule appears to be an ideal technique by which to examine All's effect. Deep convolutions are easily accessible, dissected tubules are free ofsympathetic nerve endings by electron microscopy (Tisher, C. Craig, personal communication), and transport mechanisms are relatively easily defined. Although one early isolated tubule study found no effect of 10-6 M bath All on proximal volume reabsorption (18), we have reexamined All effects using this technique and have found a direct, biphasic dose response of All on proximal volume reabsorption.
Methods
AII radioimmunoassay (RIA) and plasma levels. All concentration was measured in plasma using an RIA developed by Arant and Stephenson (19) . This assay has a lower limit sensitivity of -3 pg/ml and a crossreactivity with All of "60%. Plasma levels were measured in three groups of rabbits: (a) normal rabbits on standard laboratory chow (Wayne Feeds; Chicago, IL) and tap water, who gained an average of 0.26±0.03 kg/wk, (b) normal rabbits given furosemide, 2.0 mg/kg s.c. body weight, followed by 7 d of a zero-sodium diet (ICN Nutritional Biochemicals, Cleveland, OH) and distilled water, during which time the mean weight loss was 0.1 1±0.06 kg, and (c) rabbits 7-14 d postadrenalectomy (20) fed normal rabbit chow and 0.9% saline for drinking water. At decapitation, free-flowing mixed arteriovenous blood was collected in chilled heparin-containing beakers, centrifuged, and the plasma immediately placed in tubes containing 250 mM 1,10 ortho-phenanthroline and 125 mM EDTA for RIA.
AII bioassay and stability in tubule baths. To determine stability of synthetic All in various standard isolated tubule baths, a bioassay for All was used (21) . Briefly, rat stomach and colon strips were mounted on tension transducers and superfused with oxygenated Ringer's solution. Spontaneous muscular activity was abolished with a variety of neuromuscular blockers (21) , and contractile responses to 1 and 10 ng 5-ileAll (Beckman Instruments, Inc., Palo Alto, CA) were recorded. 5-ileAll was incubated in commercial rabbit serum (Irvine Scientific; Santa Ana, CA) or Ringer's bicarbonate plus 5% vol/vol fetal calf serum (Pelfreez Biologicals; Rogers, AR) at 370C, or in Ringer's bicarbonate plus 6 g/l00 ml bovine serum albumin (CRG-7, Armour Pharmaceutical Co., Kankakee, IL) at room temperature and at 37°C.
Microperfusion-general experimental features. Normal rabbits on regular laboratory chow were used in all microperfusion experiments. The general methods of Burg and Orloff (18) 5 . This solution also contained 6 g/100 ml defatted bovine serum albumin (CRG-7). The perfusate was an ultrafiltrate of the bath, prepared by pressure dialysis through Amincon PM-30 membranes (American Instrument Co., Silver Springs, MD). Baths were bubbled at 37°C with 95% OJ 5% CO2 to pH 7.40, drawn anaerobically into syringes, and pumped through the perfusion chamber at 20.6 cm3/min. We have previously shown by on-line bath pH electrodes that this method produces extremely stable bath pH (22). Perfusate was equilibrated with 95% OJ5% CO2 at 37°C, and 3H-inulin was added (see below). Osmolality of bath and perfusate were matched at 295 mosM with small additions of water or NaCl.
Microperfusion-net volumeflux (J,) measurements. J, was measured using perfusate methoxy3H-inulin (New England Nuclear, Boston, MA) exhaustively dialyzed by the method of Schafer et al. (23) . J, was calculated from the equation: J, = V1 -VO/L, where V, is the perfusion rate in nanoliters per minute, V0 is the collection rate in nanoliters per minute, and L is the tubule length in millimeters. V0 was measured directly, and V, was calculated from V0 = cpmo/cpmi, where cpm. and cpmi are 3H counts per minute per nanoliter of collected and perfused fluid, 508 respectively. L was measured directly by eyepiece micrometer. Care was taken to maximize sensitivity and precision of J, measurements.2
Microperfusion-experimental protocol. The general protocol was the same in all experiments. After being hooked up to the pipettes, the tubule was warmed to 370C and allowed to equilibrate for 30 min. During this and all subsequent periods the bath contained 1% vol/vol All vehicle: Tris, 50 mM; glycine, 100 mM, BSA, 0.2 g/100 ml, pH 5.0. This vehicle did not measurably change the bath pH or osmolality. After the equilibration period, control period collections were made (see below). The continuously flowing bath was then changed to contain 5-ileAll, the 5-position moiety thought to be normally circulating in the rabbit (24) , and/or saralasin. Synthetic 5-ile-AII or saralasin (Beckman Instruments, Inc.) was dissolved in the vehicle described above, aliquoted, and frozen until just before serial dilution and addition to the bath. Fresh stock solution was made frequently. 30 min after exposure of the tubule to All a second group of collections was made. In some experiments done with All at 10-11 M, bath remaining in the infusion syringe at the end of the experimental period was assayed for All concentration by RIA as described above. The concentration at 10-" M should be 10.4 pg/ml. Measured values were 11.78±0.62 (SEM) pg/ml (n = 5), demonstrating presence of All in the bath at the desired concentration. All experiments except those with All plus saralasin contained a third (recovery) period in which the bath again contained only vehicle. 30 min after beginning this period, a final set of collections was made. Five collections were made per period.
Statistics. For any given tubule the means of four to five collections per period were used as values for that tubule. The group means for the control, experimental, and recovery periods were then computed using each tubule mean. In addition, to avoid loss of statistical power due to variability of control J, values, the experimental and recovery tubule means were also calculated as percent changes from the control 2. For a given experimental perturbation, the minimum increment or decrement of J, that can be detected is a function of the precision with which the CVP is filled, and the counting accuracy, a square-root function of the total counts. In turn, total counts are determined by perfusate counts per nanoliter, tubule length, J, perfusion rate, CVP volume, and total time the collected fluid is counted. With regard to precision of filling the CVP, triplicate calibrations performed daily had a total range around the mean of ±0.5%. During an experiment, collections for any given experimental period were made in quintuplicate to minimize sampling error. With regard to counting accuracy, the following mean values apply to these experiments: tubule length, 1.28 mm; perfusate 3H counts, 61.9 cpm/nl; CVP, 160 nl; Jv, 0.747 nl/mm per min; Vi, 12.1 nl/min. All samples were counted for 10 min in a Tracor model 6892 liquid scintillation counter (Tracor Analytic; Atlanta, GA). Thus, under these circumstances, the total mean counts for one collection are 108,570±329, or ±0.30%. Using the formula above for J, and the mean values given, a 0.30% variation in collected counts would appear as a variation in J, of ±0.026 nl/mm per min, i.e., the mean detectable change in J, above counting "noise" is 0.026 nl/mm per min, assuming 0% variability in filling ofthe CVP. Even by assuming worst-case additive random errors, i.e., scintillation counting at the upper end ofthe variation range plus overfilling the CVP by 0.5%, with both occurring only during the experimental period, the mean minimal detectable change in J, rises to 0.069 nl/mm per min, still smaller than the smallest mean change seen with All in these experiments. tubule means. Student's two-tailed t test for paired samples was used for mean values derived from the same tubule; the t test for unpaired samples was used for mean values from different tubules. Differences were considered significant if P < 0.05. Other values such as tubule length, VT, and perfusion rate are expressed as mean±SEM.
Results
Circulating plasma All levels. Plasma All concentration was measured by RIA in the rabbit as a rough approximation of renal cortical values. As shown in Fig. 1 , the mixed arteriovenous plasma All concentration of normal rabbits was 18.5±4 pg/ml. This value rises with maneuvers stimulating renal sodium retention, i.e., diuretic-and-diet-induced sodium depletion and adrenalectomy, to 30.4±4 pg/nl and 43.7±10 pg/ml, respectively (P < 0.05 normal vs. adrenalectomy). These values translate into molarities of -2 X 10-" M for normals and .5 X 10-" M for adrenalectomized rabbits.
Stability ofAll in various isolated tubule baths. To insure the presence of All at desired concentrations in the bath throughout the experiment, the stability of synthetic All was examined by bioassay following incubation in three standard microperfusion baths. As shown in Fig. 2 , rapid loss ofbioactivity occurred in commercial rabbit serum, with a t½ of -10 min. Likewise, the addition of 5% vol/vol fetal calf serum to Ringer's solution led to a loss of -50% of initial activity. On the contrary, incubation in Ringer's solution plus 6 g/100 ml albumin led to a very slight loss of activity at 370C, the temperature in the perfusion chamber, and to no loss of activity at 230C, the temperature of the infusion syringe containing bath plus hormone. Ringer's bicarbonate plus albumin was therefore used in all microperfusion experiments.
Response of J, to physiological doses ofAIL In all microperfusion experiments, All was added to the bath only, since this is the most likely site for a control function of All on the proximal tubule (25), and because luminal All has been shown Figure 2 . Stability of All in three standard microperfusion baths. Each point represents the mean of two determinations, which varied by <6%. The open circles represent the incubation conditions which predominated during the microperfusion experiments, i.e., All remained in a syringe in Ringer's plus albumin at 230C until the moment it entered the perfusion chamber, when it was warmed to 37aC. to be rapidly hydrolyzed to small peptide fragments in this segment (26) . As shown in Fig. 3 When 10-10 M All was added to the bath, a smaller increase in J, was seen. As shown in Fig. 4 , All caused J, to rise in seven tubules and to fall slightly in two tubules. Mean J,'s were (27) (28) (29) . These have been predicated on the concept that, as in vascular beds, saralasin acts as a nearly pure antagonist with little, if any, intrinsic agonistic action. However, in superficial proximal convoluted tubules, some studies have suggested that saralasin is agonistic at 10-8 M (30) and at 10-7 M (12). In the jejunum, Levens et al. (31) found saralasin agonistic at both low and high doses. Saralasin was therefore examined for intrinsic agonistic activity in rabbit nonsurface proximal convoluted tubules.
An attempt was made to mimic in vitro the peritubular saralasin concentrations that would prevail in vivo in the micropuncture studies cited above (27) (28) (29) . Pharmacokinetic data on saralasin plasma levels at various systemic infusion rates were taken from a study by Pettinger et al. (32) and plotted as a linear regression in Fig. 6 . The systemic saralasin infusion rates used in references 27 and Effects ofsaralasin plus AII. In five tubules, both saralasin at 10-7 M plus AII at 10-1" M were added in concert. This in vitro experiment thus approximated the in vivo saralasin studies previously cited. As shown in Fig. 8 , saralasin, at this peritubular concentration, completely blocked the stimulatory effect of 10-" M AIl. The J,'s for control and saralasin-plus-AII periods were 0.65±0.05 and 0.61±0.10 nl/mm per min (NS). The perfusion rates were 10.19±0.67 and 10.41±0.62 nl/mm per min, respectively.
AH effect on VT. In our laboratory, proximal tubules meeting morphological criteria for experimentation tend to have an increase in lumen-negative VT throughout the experiment. This increase in VT is relatively rapid for -1-2 h and then appears to approach an asymptote. Fig. 9 shows VT vs. time in two representative All experiments. As shown, neither high-dose (10-' M) nor low-dose (10-10 M) All, which had opposite effects on Jv, noticeably altered VT. Likewise, the rate of rise of VT, i.e., the slope of this curve, did not change upon addition of All, nor were the slopes different in the time controls compared with All experiments (data not shown). Therefore, both stimulatory and inhibitory effects of All on J, appeared to be electroneutral.
Discussion
These studies are important in that they: (a) demonstrate a direct effect of plasma All levels in rabbits by RIA. Our data also confirm the biphasic dose-response pattern seen in other studies. Three major aspects of our studies deserve particular attention: the directness, magnitude, and mechanism ofthe All effect.
Studies examining a possible direct effect ofAll on epithelial transport have been complicated by interactions with the sympathetic nervous system. Angiotensin's ability to enhance norepinephrine release from sympathetic nerve endings is well known (16) . Indeed, the stimulation of jejunal volume reabsorption by low doses of All appears due solely to the release of norepinephrine (33) , whereas the effects on colonic transport persist after denervation (2) . In the kidney, the initial clearance studies by McGiff(34) (30, 37) . Although the precise function of each set of receptors remains to be determined, current evidence suggests that luminal All undergoes rapid hydrolysis with tubular uptake of fragments (26), whereas basolateral All produces changes in epithelial transport (12, 13 (27, 38) . It is not clear if this change in All effect represents a change in tubule responsiveness to All or some other intrarenal action of All. Our normal rabbits are on a relatively high-sodium diet. We therefore attempted to examine the effects of All on tubules harvested from sodium-depleted rabbits. However, these proximal convoluted tubules were extremely friable upon dissection, and no tubules of sufficient viability for these experiments were obtained. No attempts were made at perfusing convolutions from adrenalectomized rabbits.
We examined the competitive All antagonist saralasin. Some data have suggested that the action of saralasin in relationship to All is different in epithelial as opposed to vascular tissues. In the rat jejunum, saralasin is agonistic at all doses. It does not antagonize the stimulatory effects of low-dose All, and it blocks the inhibitory effect of high-dose All, allowing the latter to be stimulatory (31) . In renal tubules, saralasin alone has been reported to be stimulatory at 10-' M (12) and at 10-9 M (30).
We addressed this issue by first examining saralasin alone at a dose (10-7 M) which probably prevailed in micropuncture experiments using saralasin infusions, and found no significant agonistic activity. In addition, this dose prevented the rise in J, seen with 10-I M All. These experiments are thus consistent with an action of saralasin on the proximal tubule as an All receptor antagonist only. It is possible, however, that other saralasin-AII dose combinations could yield other results. The action of All on the proximal convolution appears to involve an electroneutral transport process(es), at least as assessed by VT. This is characteristic of All's action in other epithelia, i.e., colon, (4), jejunum (3), and gallbladder (39). In the proximal tubule, Harris and Young (13) indirectly assessed VT by measuring chloride distribution across the epithelium. Although they found no effect of All on VT, their method is based on the assumption that all chloride movement is passive and paracellular. However, recent evidence has suggested that at least a portion ofchloride movement may be transcellular and coupled to sodium entry (40) , therefore challenging the validity of this method. Our studies directly measured VT at the lumen pipette and found no measurable change with All at doses that either stimulated or inhibited J,. It is, of course, possible that the relatively small changes in J, (0.100 nl/mm per min) induced by All were associated with proportionately small changes in VT which went undetected. The relationship between J, driven by electrogenic processes (i.e., coupled organic solute co-transport) and the contribution of these processes to VT have not been systematically examined. Extrapolation from several available studies (15, 41, 42) suggests that electrogenic processes produce changes in VT of 0.3-1.2 mV per 0.100 nl/mm per min change in J,. Our system should be able to detect changes of this magnitude. The larger changes in J, produced by highdose All probably should have produced detectable changes in VT. We did not observe such changes. However, the transport process(es) inhibited by high-dose All may not be the same one(s) stimulated by physiologic concentrations. In any event, further experiments with All involving omission of luminal organics are required to be confident that the All effect is electroneutral.
The intracellular mechanism of J, stimulation at low doses and inhibition at high doses remains speculative. Many peptide hormones appear to alter transport via effects on cyclic AMP. Available evidence, however, suggests that All does not raise, and may even lower, cyclic AMP levels in renal cortex (43) (44) (45) (46) . Since cyclic AMP inhibits J, in the proximal tubule (47), a fall in cyclic AMP might stimulate J,. On the other hand, changes in cytosolic calcium activity, a mediator of All action in many tissues, might produce the effects seen here. Although some studies have shown inhibition of J, in the proximal tubule with maneuvers thought to increase cytosolic calcium (48) , others have shown enhanced J, (49) . Moreover, sodium entry into cultured epithelial cells is enhanced when cytosolic calcium is moderately raised. However, when calcium loading is extended still further, stimulation of sodium entry falls below the peak value (50) . It is therefore possible that progressively larger increases in cytosolic calcium, due to All, might produce the biphasic dose response. The stimulation of transport might be mediated through cyclic AMP-independent protein phosphorylation, as has been shown to occur in the hepatocyte (1). The inhibitory effect might be a direct action of calcium per se on sodium transport (48) , or could be due to stimulation of prostaglandin synthesis by calcium, though the evidence for a significant role of prostaglandins in the proximal tubule is poor (5 1). The role of cytosolic calcium in the action ofany hormone on renal tubules, and of All in particular, remains poorly understood.
